Interview with Petr Tor, Country Director, Stallergenes Czech Republic
Mr. Tor, prior to joining Stallergenes in 2010, you had been with MSD for nearly two decades. After such a prolonged experience at a major global pharma player, why did…
Egis Pharmaceuticals PLC is one of the leading generic pharmaceutical companies in Central Eastern Europe with activities extending to every field of pharmaceutical production from research and development, through active ingredient and finished production to sales and marketing.
In the past one hundred years that have passed since the foundation of Egis in 1913, Egis has grown into an internationally renowned company with about 4000 employees worldwide.
Egis products are sold to 60 countries and 75 percent of its turnover derives from exports. Egis drugs acting on the cardiovascular, central nervous and respiratory systems account for almost three-quarters of our turnover and we are continuously open towards new areas. In 2013, Egis launched Europe’s first biosimilar monoclonal antibody and it is our strategic goal to become a key player in the biosimilar therapies’ segment.
Contact
Address: Ovocný trh 1096/8, Praha, Czech Republic
Phone number: +420 227 129 111
Homepage: http://www.egispraha.cz/
Mr. Tor, prior to joining Stallergenes in 2010, you had been with MSD for nearly two decades. After such a prolonged experience at a major global pharma player, why did…
Mr. Pfannenschmidt, you have been working for Boehringer Ingelheim for three decades, outlasting several company chairman and witnessing the birth and evolution of the corporate vision “Value through Innovation”. Before…
Mr. Bruzl, we often interview pharmaceutical managers that studied medicine, pharmaceutical science, or business—we do not interview many managers that have a background in law. How did you find yourself…
Infirmary and ultimately leading to a position heading the Czech Republic and Slovakian organization for Janssen. Can you begin by introducing yourself to our readers and giving them an overview…
Mr. Pospíšil, you have quite an interesting background, with a degree in agricultural economy engineering. You eventually left the field in 1991 to consult for Lundbeck, building the business here.…
Mr. Gyürüsi, Gedeon Richter is a 111-year-old company that is synonymous with the Central and Eastern European pharma industry. The business has been present in Czechoslovakia since 1956, and has…
Dr. Janda, can you please begin by introducing our readers to the ACRO-CZ, and explicate its mission on this market? Mimicking the European standards, we also wanted to connect all…
The Czech Republic is home to Apotex’s oldest branch within a Europe, established in 1992. You yourself joined the organization in 1993. What has been this company’s growth trajectory in…
Mr. Bartoš, you are celebrating your 15th anniversary with Merck this year, and your international career has offered you the opportunity to work throughout Europe. Over these years, how have…
Dr. Zörner, can you please begin by introducing our readers to the CAFF (Czech Association of Pharmaceutical Firms), and explicate its key activities and mission? We represent 24 companies in…
Mr. Březovký, can you begin with an introduction to SUKL and its role within the Czech Republic’s complex regulatory environment? I would like to begin by noting that I have…
In the Czech Republic, homeopathic medicines were prohibited during the communistic period, but found resurgence after 1989. Can you give us an overview of the development of this form of…
See our Cookie Privacy Policy Here
